J. Goldman & Co LP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$2,639,000
-1.5%
115,000
-18.2%
0.18%
+34.1%
Q2 2018$2,679,000
-21.6%
140,647
-30.6%
0.14%
-4.8%
Q1 2018$3,415,000
-34.2%
202,648
-56.3%
0.14%
-46.5%
Q2 2016$5,191,000
-28.7%
463,900
-46.7%
0.27%
-40.0%
Q1 2016$7,282,000
-13.4%
871,000
-3.5%
0.45%
-47.9%
Q4 2015$8,405,000
-0.9%
902,839
+20.1%
0.87%
+19.4%
Q3 2015$8,480,000
-27.8%
751,760
-18.8%
0.73%
+1.7%
Q2 2015$11,753,000
+116.3%
926,184
+58.5%
0.71%
+112.5%
Q1 2015$5,434,000
-20.1%
584,285
+23.1%
0.34%
-58.3%
Q4 2014$6,797,000
-38.2%
474,673
-55.2%
0.80%
+21.1%
Q3 2014$11,003,000
+255.5%
1,060,000
+454.2%
0.66%
+193.0%
Q2 2014$3,095,000
+237.1%
191,250
+158.4%
0.23%
+97.4%
Q4 2013$918,000
-43.2%
74,000
-49.8%
0.12%
-23.8%
Q3 2013$1,615,000
-34.9%
147,500
-52.0%
0.15%
-40.6%
Q2 2013$2,480,000307,0000.25%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders